The REJOICE trial: a phase 3 randomized, controlled trial evaluating the safety and efficacy of a novel vaginal estradiol soft-gel capsule for symptomatic vulvar and vaginal atrophy Article

sustainable development goals

authors

publication date

  • April 1, 2017

webpage

published in

keywords

  • Dyspareunia
  • Estradiol
  • Estrogen therapy
  • Menopause
  • Vaginal atrophy

start page

  • 409

end page

  • 416

volume

  • 24

issue

  • 4